Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trident LifelineBOM:543616 +1.55%74 Return-on-Tangible-Equity is 24.46% as of Jun. 2026, which is 5% below its 10-year median of 25.79. GuruFocus rates BOM:543616 with a GF Score™ of 74/100 and a GF Value™ of ₹606.47 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 576 Healthcare Providers & Services companies, Trident Lifeline ranks better than 77.08% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Trident Lifeline's annualized net income for the quarter that ended in Jun. 2026 was ₹201 Mil. Trident Lifeline's average shareholder tangible equity for the quarter that ended in Jun. 2026 was ₹823 Mil. Therefore, Trident Lifeline's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2026 was 24.46%.
The historical rank and industry rank for Trident Lifeline's Return-on-Tangible-Equity or its related term are showing as below:
BOM:543616'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 13.89 Med: 25.79 Max: 333.74
Current: 30.26
During the past 7 years, Trident Lifeline's highest Return-on-Tangible-Equity was 333.74%. The lowest was 13.89%. And the median was 25.79%.
BOM:543616's Return-on-Tangible-Equity is ranked better than 77.08% of 576
companies
in the Healthcare Providers & Services industry
Industry Median: 10.605
vs BOM:543616: 30.26
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Trident Lifeline Return-on-Tangible-Equity Related Terms
Trident Lifeline Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Trident Lifeline's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, Trident Lifeline's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trident Lifeline Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Trident Lifeline's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Trident Lifeline's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 24.46% mean?
Trident Lifeline (BOM:543616) has a Return-on-Tangible-Equity of 24.46% as of Jun. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Trident Lifeline and its competitors. This is near median its historical median of 25.79. Over the past decade, Trident Lifeline's Return-on-Tangible-Equity has ranged from 13.89 to 333.74. According to the industry distribution chart, Trident Lifeline ranks #132 out of 576 companies in the Healthcare Providers & Services industry, placing it in the top 22.9%.
Is Trident Lifeline's Return-on-Tangible-Equity too high?
Trident Lifeline's current Return-on-Tangible-Equity of 24.46% is near median its 10-year median of 25.79. Over the past 10 years, this metric has ranged from a low of 13.89 to a high of 333.74. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.61. Trident Lifeline's value of 24.46% is 130.6% above this industry median. Based on the distribution chart, Trident Lifeline ranks #132 out of 576 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Trident Lifeline has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trident Lifeline's Return-on-Tangible-Equity compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Trident Lifeline ranks #132 out of 576 companies for Return-on-Tangible-Equity. This places Trident Lifeline in the top 23% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 10.61. Trident Lifeline's value of 24.46% is 130.6% above this benchmark. Historically, Trident Lifeline's own Return-on-Tangible-Equity has ranged from 13.89 to 333.74 over the past decade. While the company's 10-year median is 25.79 vs. the industry median of 10.61, Trident Lifeline has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.61, based on 576 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trident Lifeline's current Return-on-Tangible-Equity of 24.46% is 130.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Trident Lifeline and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trident Lifeline's current Return-on-Tangible-Equity is 24.46%, which is near median its own 10-year median of 25.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trident Lifeline stock overvalued right now?
Based on GuruFocus' analysis, Trident Lifeline (BOM:543616) is currently considered Possible Value Trap. The stock's GF Value™ is ₹606.47, compared to a current price of ₹258.45 — trading 57.4% below its estimated fair value. The current Return-on-Tangible-Equity is 24.46%, which is near median its 10-year median of 25.79 and 130.6% above the Healthcare Providers & Services industry median of 10.61. Trident Lifeline's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Trident Lifeline (BOM:543616), the current Return-on-Tangible-Equity is 24.46% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trident Lifeline (BOM:543616) Overvalued in 2026?
Based on GuruFocus' analysis, Trident Lifeline stock appears to be undervalued.
The current stock price of ₹258.45 is trading 57.4% below its estimated GF Value™ of ₹606.47.
GuruFocus considers Trident Lifeline to be Possible Value Trap.
Key valuation signals for BOM:543616:
Return-on-Tangible-Equity: 24.46% (near median its 10-year median of 25.79)
GF Value™: ₹606.47 vs. price of ₹258.45 (57.4% below fair value)
Industry Position: 130.6% above the Healthcare Providers & Services median (#132 of 576)
No single metric tells the full story. See the BOM:543616 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trident Lifeline Ltd is engaged in the marketing of pharmaceutical products in domestic as well as international market. The company is also engaged in distribution of pharmaceutical products through third-party distribution network. It also offers a wide range of pharmaceutical formulations and products manufactured on contract manufacturing under a loan license. The Company's reportable geographical segments include India, Ghana, Kenya, Peru, Cameroon, Venezuela, and the Rest of World.
74GF Score
Get the complete analysis for BOM:543616
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543616 has been successfully added to your 
